Xtant Medical Hldgs Q3 2024 GAAP EPS $(0.04) Misses $(0.03) Estimate, Sales $27.937M Miss $29.300M Estimate
Xtant Medical Hldgs Q3 2024 GAAP EPS $(0.04) Misses $(0.03) Estimate, Sales $27.937M Miss $29.300M Estimate
xtant medical控股公司2024年第三季度GAAP每股收益爲$(0.04)，低於$(0.03)的預期，銷售額爲2793.7萬美元，低於2930萬美元的預期
Xtant Medical Hldgs (AMEX:XTNT) reported quarterly losses of $(0.04) per share which missed the analyst consensus estimate of $(0.03) by 33.33 percent. The company reported quarterly sales of $27.937 million which missed the analyst consensus estimate of $29.300 million by 4.65 percent. This is a 11.66 percent increase over sales of $25.019 million the same period last year.
xtant medical控股（美交所：XTNT）報告每股虧損$(0.04)，低於分析師一致預期$(0.03)的33.33%，該公司報告的季度銷售額爲2793.7萬美元，低於分析師一致預期的2930萬美元的4.65%，較去年同期的2501.9萬美元銷售額增長11.66%。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間